'Value Enhancement Plan' Could Transform Operations at MindMed. What the Founder Says Is Ahead At The Psychedelic Biotech
FCM MM Holdings sent a letter to MindMed’s (NASDAQ: MNMD) board of directors calling on them to adopt a new strategic plan to "turn the company around.”
